Deerfield Partners, L.P. is 10% Owner at Aclaris Therapeutics, Inc. (ACRS). They have made 11 open-market trades across 7 companies since 2016, most recently 2020-07-28.
3 open-market purchases totalling $17.8M since 2020, against 8 sales. Too few scored purchases to measure a record yet.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 63% | 63% | 75% |
| Avg Move | -18.2% | -20.7% | -22.6% |
| Scored | 8 | 8 | 8 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ANNX | BUY | 2020-07-28 | 2020-07-28 | $17.00 | $6.0M | +20.5% | +32.3% | +38.4% |
| GBIO | BUY | 2020-06-16 | 2020-06-16 | $19.00 | $4.3M | +1.9% | -11.3% | +42.1% |
| BDTX | BUY | 2020-02-03 | 2020-02-03 | $19.00 | $7.6M | -1.7% | -19.2% | -0.7% |
| FIXX | SELL | 2020-01-29 | 2020-01-31 | $15.45 | $16.0M | +22.8% | +7.6% | -23.6% |
| ACRS | SELL | 2019-06-25 | 2019-06-25 | $4.51 | $184K | -51.7% | -60.7% | -71.1% |
| ACRS | SELL | 2019-06-24 | 2019-06-25 | $4.52 | $286K | -51.7% | -60.7% | -71.1% |
| ACRS | SELL | 2019-06-21 | 2019-06-25 | $4.59 | $2.1M | -51.7% | -60.7% | -71.1% |
| ACRS | SELL | 2019-06-21 | 2019-06-25 | $4.62 | $1.6M | -51.7% | -60.7% | -71.1% |
| MNK | SELL | 2018-05-09 | 2018-05-10 | $13.39 | $8.4M | +11.2% | +32.1% | +102.4% |
| EHTH | SELL | 2017-04-26 | 2017-04-27 | $11.66 | $5.0M | +35.4% | +46.9% | +48.3% |
| EHTH | SELL | 2016-06-20 | 2016-06-22 | $14.21 | $5.4M | -8.1% | -9.4% | -23.2% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.